CCAP vs. CORZ, WULF, VEL, HUT, QD, LDI, RWAY, MDBH, GHI, and LX
Should you be buying Crescent Capital BDC stock or one of its competitors? The main competitors of Crescent Capital BDC include Core Scientific (CORZ), TeraWulf (WULF), Velocity Financial (VEL), Hut 8 (HUT), Qudian (QD), loanDepot (LDI), Runway Growth Finance (RWAY), MDB Capital (MDBH), Greystone Housing Impact Investors (GHI), and LexinFintech (LX). These companies are all part of the "nondepository credit institutions" industry.
Crescent Capital BDC (NASDAQ:CCAP) and Core Scientific (NASDAQ:CORZ) are both small-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their community ranking, dividends, earnings, risk, profitability, media sentiment, analyst recommendations, institutional ownership and valuation.
Crescent Capital BDC has higher earnings, but lower revenue than Core Scientific.
Crescent Capital BDC presently has a consensus price target of $18.67, suggesting a potential upside of 3.76%. Core Scientific has a consensus price target of $6.75, suggesting a potential upside of 84.43%. Given Core Scientific's stronger consensus rating and higher probable upside, analysts plainly believe Core Scientific is more favorable than Crescent Capital BDC.
Crescent Capital BDC has a net margin of 53.32% compared to Core Scientific's net margin of 0.00%. Crescent Capital BDC's return on equity of 11.99% beat Core Scientific's return on equity.
Crescent Capital BDC received 15 more outperform votes than Core Scientific when rated by MarketBeat users. Likewise, 54.72% of users gave Crescent Capital BDC an outperform vote while only 40.00% of users gave Core Scientific an outperform vote.
49.5% of Crescent Capital BDC shares are owned by institutional investors. 1.1% of Crescent Capital BDC shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
In the previous week, Crescent Capital BDC had 12 more articles in the media than Core Scientific. MarketBeat recorded 19 mentions for Crescent Capital BDC and 7 mentions for Core Scientific. Crescent Capital BDC's average media sentiment score of 0.93 beat Core Scientific's score of 0.74 indicating that Crescent Capital BDC is being referred to more favorably in the media.
Summary
Crescent Capital BDC beats Core Scientific on 10 of the 13 factors compared between the two stocks.
Get Crescent Capital BDC News Delivered to You Automatically
Sign up to receive the latest news and ratings for CCAP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CCAP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Crescent Capital BDC Competitors List
Related Companies and Tools
